MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Prodromal Parkinson’s Disease in Agent Orange Exposed US Vietnam Veterans

E. Uc, C. Weber, M. Lenz, J. Dawson (Iowa City, USA)

Meeting: 2025 International Congress

Keywords: Disease-modifying strategies, Neuroprotective agents, Parkinson’s

Category: Parkinson's Disease: Epidemiology, Phenomenology, Clinical Assessment, Rating Scales

Objective: 1-Comparing the risk of prodromal PD between AO exposed veterans (AOEV) and non-AO exposed veterans without PD (Controls) in a Veterans Affairs (VA) hospital neurology clinic. 2-Comparing the clinical characteristics of probable prodromal PD (ppPD) to PD and Controls.

Background: AO exposure increases the risk of PD. In prodromal PD, non-motor and early motor symptoms of PD are present, but motor impairment is not enough to confirm the clinical diagnosis of PD.

Method: A convenience sample of 144 participants (all men, at least 65 years old) from a VA hospital neurology outpatient clinic participated in a biomarker study and underwent testing using MDS-UPDRS, MoCA, and questionnaires on non-motor features of PD. AOEV without PD were recruited from Vietnam veterans who were on AO benefits from the VA. The total likelihood ratio for probable prodromal PD for AOEV and Controls was calculated using the “Prodromal PD Calculator” on the MDS website (Heinzel et al. Update of the MDS Research Criteria for Prodromal PD. Mov Disord 2019). Estimated probability of ≥80% was required for classification as ppPD.

Results: No Control participant (n=30, median age=71.5 years) was classified as ppPD, whereas 15 of 54 AOEV participants (median age=76) were classified as ppPD (p<0.001).. Comparison of the ppPD (n=15, median age=74) to Controls (expanded to n=69 with addition of AOEV without ppPD or PD, median age 75) showed no difference in age, MoCA, MDS-UPDRS Parts II (motor experiences of daily living), and III (motor examination), but worse (p<0.05) scores in the Geriatric Depression Scale (GDS), MDS-UPDRS  Part I (non-motor experiences of daily living), and PD Sleep Scale-2 (PDSS-2). Comparison of the ppPD to PD (n=60, median age=75, median Hoehn-Yahr stage=2) showed no difference in age, MoCA, GDS, PDSS-2, and MDS-UPDRS Part I, but better (p<0.05) scores in MDS-UPDRS Parts II and III.

Conclusion: Exposure to AO increases the risk of prodromal PD in veterans. Consistent with expectations, the ppPD group had worse non-motor symptoms compared to Controls but without worse motor function, and had better motor function compared to PD but with similar non-motor symptoms. Veterans with AO exposure represent an enriched population for prodromal PD and could be considered as a target population to test the effects of potential neuroprotective treatments early in the course of PD.

To cite this abstract in AMA style:

E. Uc, C. Weber, M. Lenz, J. Dawson. Prodromal Parkinson’s Disease in Agent Orange Exposed US Vietnam Veterans [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/prodromal-parkinsons-disease-in-agent-orange-exposed-us-vietnam-veterans/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/prodromal-parkinsons-disease-in-agent-orange-exposed-us-vietnam-veterans/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley